Successful bortezomib-based treatment in POEMS syndrome

European Journal of Haematology

Volumn 83, Issue 6, 2009, Pages 609-610

  Tang, Xiaowen ^b,c   Shi, Xiaolan ^b,c   Sun, Aining ^b,c   Qiu, Huiying ^b,c   Gu, Bin ^b,c   Zhou, Huifen ^b,c   Xue, Shengli ^b,c   Liu, Yuejun ^b,c   Ruan, Changgeng ^b,c   Wu, Depei ^a,b,c  

^a 188 Shizi Road ^*  (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MELPHALAN; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VINCRISTINE;

ADULT; CASE REPORT; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FOLLOW UP; GYNECOMASTIA; HUMAN; LABORATORY TEST; LEG EDEMA; LETTER; MALE; MULTIPLE CYCLE TREATMENT; PARESTHESIA; POEMS SYNDROME; PRIORITY JOURNAL; REMISSION; SPLENOMEGALY; WEAKNESS;

ADULT; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; CYCLOPHOSPHAMIDE; CYTARABINE; DEPRESSION, CHEMICAL; DEXAMETHASONE; DOXORUBICIN; DRUG THERAPY, COMBINATION; HUMANS; MALE; MELPHALAN; PLASMA CELLS; POEMS SYNDROME; PREDNISONE; PROTEASE INHIBITORS; PYRAZINES; REMISSION INDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VINCRISTINE;

EID: 70449495773     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01330.x     Document Type: Letter

References (9)

1. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003 101 : 2496 2506.
2. Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, Tsubaki T, Igata A, Ozaki Y. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984 34 : 712 720.
3. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore) 1980 59 : 311 322.
4. Dispenzieri A. POEMS syndrome. Blood Rev 2007 21 : 285 299.
5. Soubrier M, Dubost JJ, Serre AF, Ristori JM, Sauvezie B, Cathebras P, Piette JC, Chapman A, Authier FJ, Gherardi RK. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 1997 40 : 786 787.
6. Hitoshi S, Suzuki K, Sakuta M. Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease. Intern Med 1994 3 : 583 587.
7. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996 347 : 702.
8. Nakano A, Mitsui T, Endo I, Takeda Y, Ozaki S, Matsumoto T. Solitary plasmacytoma with VEGF overproduction: report of a patient with polyneuropathy. Neurology 2001 56 : 818 819.
9. Ladetto M, Astolfi M, Santo L, et al. Impact of early consolidation with bortezomib, thalidomide and dexamethasone on molecularly-detectable disease in MM patients in CR or VGPR following autologous transplantation: uncommon achievement of molecular remission despite evidence of tumor load reduction by real time PCR. Blood (ASH Annual Meeting Abstracts) 2006 108 : 3100.